MedPath

Ipratropium Bromide and Albuterol Sulfate

Ipratropium Bromide and Albuterol Sulfate

Approved
Approval ID

001e3b1c-b7c1-44aa-b812-e78dbf4f3069

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 27, 2017

Manufacturers
FDA

Medical Supply Distribution, Llc.

DUNS: 080470358

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ipratropium Bromide and Albuterol Sulfate

PRODUCT DETAILS

NDC Product Code71152-201
Application NumberANDA076749
Marketing CategoryC73584
Route of AdministrationRESPIRATORY (INHALATION)
Effective DateSeptember 22, 2017
Generic NameIpratropium Bromide and Albuterol Sulfate

INGREDIENTS (5)

IPRATROPIUM BROMIDEActive
Quantity: 0.5 mg in 3 mL
Code: J697UZ2A9J
Classification: ACTIR
ALBUTEROL SULFATEActive
Quantity: 3 mg in 3 mL
Code: 021SEF3731
Classification: ACTIM
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ipratropium Bromide and Albuterol Sulfate - FDA Drug Approval Details